KWM
TMO icon

Keebeck Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Keebeck Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$392K Sell
796
-104
-12% -$56.4K 0.04% 266
2025
Q4 		$522K Buy
900
+90
+11% +$50.9K 0.06% 214
2025
Q3 		$393K Sell
810
-13
-2% -$6.05K 0.05% 253
2025
Q2 		$334K Sell
823
-59
-7% -$24.7K 0.04% 269
2025
Q1 		$439K Buy
882
+7
+0.8% +$3.79K 0.06% 181
2024
Q4 		$456K Buy
875
+42
+5% +$23.1K 0.07% 171
2024
Q3 		$516K Buy
833
+2
+0.2% +$1.18K 0.07% 167
2024
Q2 		$460K Sell
831
-115
-12% -$65.9K 0.07% 180
2024
Q1 		$550K Sell
946
-13
-1% -$7.29K 0.08% 178
2023
Q4 		$509K Buy
959
+13
+1% +$6.29K 0.08% 176
2023
Q3 		$479K Hold
946
– – 0.08% 178
2023
Q2 		$494K Hold
946
– – 0.07% 182
2023
Q1 		$546K Hold
946
– – 0.09% 154
2022
Q4 		$521K Buy
946
+14
+2% +$7.42K 0.09% 151
2022
Q3 		$473K Hold
932
– – 0.09% 155
2022
Q2 		$507K Buy
932
+135
+17% +$74.3K 0.1% 153
2022
Q1 		$471K Hold
797
– – 0.08% 166
2021
Q4 		$532K Hold
797
– – 0.09% 145
2021
Q3 		$456K Hold
797
– – 0.09% 143
2021
Q2 		$402K Hold
797
– – 0.06% 185
2021
Q1 		$364K Hold
797
– – 0.06% 183
2020
Q4 		$371K Hold
797
– – 0.06% 165
2020
Q3 		$352K Buy
797
+54
+7% +$22.3K 0.07% 147
2020
Q2 		$269K Hold
743
– – 0.09% 146
2020
Q1 		$210K Hold
743
– – 0.09% 136
2019
Q4 		$241K Buy
+743
New +$225K 0.08% 131

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Keebeck Wealth Management's TMO Position: Q1 2026 in Review

Keebeck Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q1 2026, selling an estimated $56.4K and leaving 796 shares worth $392K. The position accounts for 0.04% of the portfolio, ranked #266.

Keebeck Wealth Management first reported a position in TMO in Q4 2019 and has held it in 26 quarters since. The position peaked at $550K in Q1 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Keebeck Wealth Management held 796 shares of Thermo Fisher Scientific worth $392K as of Q1 2026.
  • Keebeck Wealth Management sold 104 Thermo Fisher Scientific shares in Q1 2026, an estimated $56.4K.
  • Thermo Fisher Scientific made up 0.04% of Keebeck Wealth Management's portfolio in Q1 2026, its #266 holding.
  • Keebeck Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 26 quarters since.
  • Keebeck Wealth Management's Thermo Fisher Scientific position peaked at $550K in Q1 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Keebeck Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.